A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...

We can take simple steps to radically increase the number of kidneys available for transplant, but political inertia has ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

Cancer operations that remove whole or parts of an organ can be life-altering. New research suggests that some patients may ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

A PRESENTER has candidly opened up on her “absolutely horrendous” experience while using Mounjaro. Danielle Mason, an ...

Prophylactic IV magnesium is associated with a reduced risk for cisplatin-associated acute kidney injury in patients with ...

Of the 422 patients, 198 (47%) experienced a recurrence following surgery. There was an almost even split between early (34%), mid (33%), and late recurrences (32%). Time to recurrence was associated ...

Dr. Kazuyuki Numakura presented a study of primary resistance to nivolumab + ipilimumab therapy affecting second-line treatment outcomes in metastatic renal cell carcinoma (mRCC) patients. Long-term ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

There are currently no proven therapies that reduce cisplatin-induced acute kidney injury (AKI) in patients with cancer.